Variant Guillain-Barré Syndrome in a patient with non-Hodgkin's lymphoma

R. H. Bishay, J. Paton, V. Abraham

Research output: Contribution to journalArticlepeer-review

Abstract

We report a 72-year-old female patient with diffuse large B cell non-Hodgkin's lymphoma (NHL) with previous treatment with standard chemotherapy presenting as an acute, ascending, sensorimotor polyneuropathy. Nerve conduction studies and lumbar puncture supported a rare, but ominous, axonal variant of Guillain-Barre Syndrome (GBS) known as acute motor and sensory axonal neuropathy (AMSAN), which is distinguished from the more common, acute demyelinating forms of GBS. Previous reports have largely focused on toxicities secondary to chemo- or radiotherapy as a major contributor to the development of acute neuropathies in malignancy. Clinicians should also be mindful of direct neoplastic invasion or, less commonly, paraneoplastic phenomenon, as alternative mechanisms, the latter possibly reflecting immune dysregulation in particularly aggressive lymphomas. At the time of writing, this is the first report in the literature of an axonal variant of GBS in a patient with diffuse large B cell NHL. A discussion regarding common and uncommon neuropathies in haematological malignancies is made, with a brief review of the anecdotal evidence supporting a paraneoplastic association with GBS or its variant forms in the setting of lymphoma.
Original languageEnglish
Article number979237
Number of pages4
JournalCase Reports in Hematology
Volume2015
DOIs
Publication statusPublished - 2015

Open Access - Access Right Statement

Copyright © 2015 R. H. Bishay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • Guillain, Barré syndrome
  • lymphomas
  • neuropathy
  • paraneoplastic syndromes

Fingerprint

Dive into the research topics of 'Variant Guillain-Barré Syndrome in a patient with non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this